Norwegian version of this page

Dermatology

Our research is mainly focusing on the following four topics: skin cancer, skin inflammation, skin microcirculation and quality of life/epidemiology.

About the group

The research group represents a selection of researchers in the Department of Rheumatology, Skin and Infection Diseases (RHI) at the University of Oslo and Oslo University Hospital.

The activities of the Dermatology Research Group are closely integrated with the clinical work at the Department of Dermatology, Oslo University Hospital.

The department is a tertiary referral center for patients with skin disease, both adults and children, in the South-East Health Region of Norway (population: appr. 2.9 million). The academic staff is also responsible for teaching medical students at the University of Oslo.

We have collaborations with several clinical and basic research groups, both at the Oslo University Hospital and at other institutions in Norway and abroad. Our aim is to increase collaborations in the future to perform high-quality Research.

The group's projects are divided into four themes

  • Skin cancer. Cancer of transplanted, metastases of spinocellular carcinoma, micrometastases of malignant melanoma, D vitamin level of transplanted and cutaneous T cell lymphoma.
  • Inflammation of the skin
  • Cutaneous physiology / epidermis
  • Quality of life / interaction

Cooperation

Internal

  • Rheumatology Research Group, OUS
  • ORAACLE - Oslo Research group of Asthma and Allergy in Children, the Lung and Environment
  • PreventADALL
  • K. G. Jebsen Inflammation Research Centre
  • Department of Pathology, OUS Radiumhospitalet.
  • Oslo Centre for Biostatistics and Epidemiology, OUS
  • Institute for Internal Medicine Research, OUS Rikshospitalet
  • Department of Medical Genetics, OUS
  • Department of Obstetrics and Gynecology, OUS Ullevål
  • Norwegian National Advisory Unit on Women’s Health, OUS
  • Department of General Practice, UiO

National

  • Janssen-Cilag AS, Oslo
  • Department of Rheumatology, Diakonhjemmet Hospital, Oslo
  • Cancer Registry of Norway, Oslo
  • Haukeland University Hospital, Centre for Medical Genetics and Molecular Medicine, Bergen
  • The Norwegian Radiation Protection Authority, Østerås

International

  • Nijmegen University Hospital, The Netherlands
  • University of the Witwatersrand, South Africa
  • University of Halifax, Canada.
  • SCOPE network (Skin Care in Organ-transplanted Patients Europe)
  • EADV Task Force Pruritus
  • European Society of Psychiatry and Dermatology

Selected Key Publications

Rehbinder EM, Winger AJ, Landrø L, Asarnoj A, Berents TL, Carlsen KH, Hedlin G, Jonassen CM, Nordlund B, Sandvik L, Skjerven HO, Söderhäll C, Vettukattil R, Carlsen KCL, PreventADALL study group (2019)
Dry skin and skin barrier in early infancy
Br J Dermatol, 181 (1), 218-219

Rehbinder EM, Advocaat Endre KM, Lødrup Carlsen KC, Asarnoj A, Stensby Bains KE, Berents TL, Carlsen KH, Gudmundsdóttir HK, Haugen G, Hedlin G, Kreyberg I, Nordhagen LS, Nordlund B, Saunders CM, Sandvik L, Skjerven HO, Söderhäll C, Staff AC, Vettukattil R, Værnesbranden MR, Landrø L, study group, Carlsen MH, Lødrup Carlsen OC, Granlund PA et al. (2019)
Predicting Skin Barrier Dysfunction and Atopic Dermatitis in Early Infancy
J Allergy Clin Immunol Pract, 8 (2), 664-673.e5

Endre KMA, Rehbinder EM, Carlsen KL, Carlsen KH, Gjersvik P, Hedlin G, Jonassen CM, LeBlanc M, Nordlund B, Skjerven HO, Staff AC, Söderhäll C, Vettukattil R, Landrø L, study group (2019)
Maternal and paternal atopic dermatitis and risk of atopic dermatitis during early infancy in girls and boys
J Allergy Clin Immunol Pract, 8 (1), 416-418.e2

Rizvi SM, Veierød MB, Mørk G, Helsing P, Gjersvik P (2019)
Ablative Fractional Laser-assisted Daylight Photodynamic Therapy for Actinic Keratoses of the Scalp and Forehead in Organ Transplant Recipients: A Pilot Study
Acta Derm Venereol, 99 (11), 1047-1048

Torp MK, Yang K, Ranheim T, Husø Lauritzen K, Alfsnes K, Vinge LE, Aukrust P, Stensløkken KO, Yndestad A, Sandanger Ø (2019)
Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts
Front Immunol, 10, 1285
 

 

Published Aug. 10, 2018 10:22 AM - Last modified May 11, 2020 2:40 PM

Contact

Group leader

Participants

Detailed list of participants